What is Champions Oncology, Inc.'s Market Cap?

Champions Oncology, Inc.'s Market Cap is $70.2M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Enterprise Value?

Champions Oncology, Inc.'s Enterprise Value is $65.4M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Price / Sales?

Champions Oncology, Inc.'s Price / Sales is 1.2×, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EV / Revenue?

Champions Oncology, Inc.'s EV / Revenue is 1.1×, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EV / EBITDA?

Champions Oncology, Inc.'s EV / EBITDA is 260.5×, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Revenue (TTM)?

Champions Oncology, Inc.'s Revenue (TTM) is $59.4M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Net Income (TTM)?

Champions Oncology, Inc.'s Net Income (TTM) is -$1.2M, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EBITDA?

Champions Oncology, Inc.'s EBITDA is $260.0K, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s Diluted EPS (TTM)?

Champions Oncology, Inc.'s Diluted EPS (TTM) is -0.08, based on as-reported figures from SEC (XBRL) filings.

What is Champions Oncology, Inc.'s EBITDA Margin?

Champions Oncology, Inc.'s EBITDA Margin is 0.4%, based on as-reported figures from SEC (XBRL) filings.

Champions Oncology, Inc. (CSBR) Financial Statements

Champions Oncology, Inc.

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S5YHT9

XNAS · usd

5.05▼ 0.17 (-3.26%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close5.22

Day's Range5.05 – 5.21

52-Week Range4.83 – 8.74

Volume15.3K

Avg Volume10.1K

Share Statistics

Shares Outstanding

Employees306

ExchangeXNAS

Listed1994-10-31

Share count as of July 23, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Champions Oncology, Inc. (CSBR)

What is Champions Oncology, Inc.'s Market Cap?: Champions Oncology, Inc.'s Market Cap is $70.2M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Enterprise Value?: Champions Oncology, Inc.'s Enterprise Value is $65.4M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Price / Sales?: Champions Oncology, Inc.'s Price / Sales is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EV / Revenue?: Champions Oncology, Inc.'s EV / Revenue is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EV / EBITDA?: Champions Oncology, Inc.'s EV / EBITDA is 260.5×, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Revenue (TTM)?: Champions Oncology, Inc.'s Revenue (TTM) is $59.4M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Net Income (TTM)?: Champions Oncology, Inc.'s Net Income (TTM) is -$1.2M, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EBITDA?: Champions Oncology, Inc.'s EBITDA is $260.0K, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s Diluted EPS (TTM)?: Champions Oncology, Inc.'s Diluted EPS (TTM) is -0.08, based on as-reported figures from SEC (XBRL) filings.
What is Champions Oncology, Inc.'s EBITDA Margin?: Champions Oncology, Inc.'s EBITDA Margin is 0.4%, based on as-reported figures from SEC (XBRL) filings.